secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2025-10-30T23:59:59+00:00
Accession:  0001193125-25-258665
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo extends shareholder rights agreement Final Expiration Date to Oct 29, 2026
--------------------------------------------------------------------------------

- Amendment No. 5 to Rights Agreement extends Final Expiration Date from Nov 2025 to Oct 29, 2026.
- Rights originally adopted Nov 8, 2020; no other terms of the agreement were changed.
- Extension covers contingent rights to purchase 1/1000th of Series A Junior Participating Preferred Stock.
- Broadridge Corporate Issuer Solutions remains rights agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000119312525258665/0001193125-25-258665-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000119312525258665/apvo-20251030.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-258665

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer